Federated Hermes Inc. trimmed its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,024,360 shares of the company's stock after selling 177,622 shares during the period. Federated Hermes Inc. owned 2.06% of Nu Skin Enterprises worth $7,058,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. bought a new position in Nu Skin Enterprises during the fourth quarter worth about $25,000. US Bancorp DE boosted its stake in shares of Nu Skin Enterprises by 424.2% during the 4th quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after acquiring an additional 6,037 shares during the period. Signaturefd LLC raised its stake in Nu Skin Enterprises by 536.8% in the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company's stock valued at $56,000 after acquiring an additional 6,817 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Nu Skin Enterprises by 2,412.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock valued at $57,000 after purchasing an additional 7,888 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Nu Skin Enterprises by 29.5% during the fourth quarter. Russell Investments Group Ltd. now owns 12,146 shares of the company's stock worth $83,000 after purchasing an additional 2,768 shares during the period. 82.84% of the stock is owned by institutional investors.
Nu Skin Enterprises Price Performance
Shares of NYSE NUS traded down $0.13 during mid-day trading on Wednesday, hitting $5.82. 108,281 shares of the stock traded hands, compared to its average volume of 745,161. The company has a market cap of $289.14 million, a PE ratio of -1.97 and a beta of 1.10. Nu Skin Enterprises, Inc. has a twelve month low of $5.74 and a twelve month high of $14.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The firm has a 50 day simple moving average of $7.26 and a two-hundred day simple moving average of $7.01.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The company had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a dividend of $0.06 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a yield of 4.13%. Nu Skin Enterprises's dividend payout ratio is currently -8.14%.
Analysts Set New Price Targets
Several brokerages have issued reports on NUS. StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. DA Davidson dropped their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a report on Friday, December 20th.
View Our Latest Stock Analysis on NUS
Nu Skin Enterprises Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Stories

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.